Why Vallon Pharmaceuticals Shares Are Trading Higher By Over 150%; Here Are 29 Stocks Moving Premarket
$AMST
$BIMI
$CJJD
$CLVS
Computer Software: Prepackaged Software
Technology
Other Pharmaceuticals
Health Care
Gainers
- Vallon Pharmaceuticals, Inc. (NASDAQ:VLON) shares rose 150.9% to $0.6313 in pre-market trading after the company entered into a definitive merger agreement with GRI Bio.
- Crown ElectroKinetics Corp. (NASDAQ:CRKN) shares rose 71.2% to $0.2243 in pre-market trading after gaining 14% on Tuesday. Crown ElectroKinetics, last month, posted a Q3 loss of $0.18 per share.
- Versus Systems Inc. (NASDAQ:VS) rose 28% to $1.00 in pre-market trading after gaining around 7% on Tuesday. Versus Systems recently announced pricing of a $2.1 million public offering.
- Senti Biosciences, Inc. (NASDAQ:SNTI) rose 17.4% to $1.69 in pre-market trading after dipping more than 21% on Tuesday.
- Scopus BioPharma Inc. (NASDAQ:SCPS) shares rose 15.8% to $0.2839 in pre-market trading.
- Clovis Oncology, Inc. (NASDAQ:CLVS) rose 12.8% to $0.1503 in pre-market trading after dropping 34% on Tuesday. Clovis Oncology voluntarily initiated a Chapter 11 proceeding in the U.S. Bankruptcy Court and will seek to sell its assets through a court-supervised sales process.
- BIMI International Medical, Inc. (NASDAQ:BIMI) rose 12.8% to $2.35 in pre-market trading. BIMI reported entry into a material definitive agreement for the acquisition of Wuzhou Qiangsheng Hospital Co., Ltd., Suzhou Eurasia Hospital Co., Ltd. and Yunan Yuxi Minkang Hospital Co., Ltd.
- Cuentas Inc. (NASDAQ:CUEN) rose 12.2% to $0.3090 in pre-market trading after gaining 8% on Tuesday.
- Root, Inc. (NASDAQ:ROOT) rose 11.9% to $5.91 in pre-market trading. TD Securities, on Monday, downgraded Root from Buy to Hold.
- ObsEva SA (NASDAQ:OBSV) rose 11.3% to $0.1703 in pre-market trading after the company announced an update on its progress towards meeting Nasdaq's minimum stockholders' equity requirement.
- HTG Molecular Diagnostics, Inc. (NASDAQ:HTGM) shares rose 9.3% to $0.7889 in pre-market trading after dropping over 29% on Tuesday. HTG Molecular Diagnostics, last month, posted a Q3 loss of $0.41 per share.
- Iveda Solutions, Inc. (NASDAQ:IVDA) rose 9% to $0.7850 in pre-market trading. Iveda, last month, launched IvedaCare, an AI-driven assistant for safety, security, and elderly care.
- Happiness Development Group Limited (NASDAQ:HAPP) rose 7.9% to $3.78 in pre-market trading after surging over 10% on Tuesday.
- Dingdong (Cayman) Limited (NYSE:DDL) rose 7.8% to $4.72 in pre-market trading after dropping over 6% on Tuesday. Dingdong (Cayman), last month, reported better-than-expected Q3 adjusted EPS results.
Don’t forget to check out our premarket coverage here .
Losers
- Drive Shack Inc. (NYSE:DS) fell 55.8% to $0.21 in pre-market trading. The company announced its intention to voluntarily delist from the NYSE and to deregister its common stock.
- Yumanity Therapeutics, Inc. (NASDAQ:YMTX) shares fell 37% to $1.28 in pre-market trading. Yumanity Therapeutics recently declared a special dividend in connection with the proposed asset sale to Janssen and merger with Kineta.
- Kaspien Holdings Inc. (NASDAQ:KSPN) fell 30.2% to $0.69 in pre-market trading after the company reported a wider Q3 loss.
- Netcapital Inc. (NASDAQ:NCPL) shares fell 28.2% to $1.58 in pre-market trading after the company reported pricing of $1,745,800 public offering of 1,247,000 shares at a price of $1.40 per share.
- Panbela Therapeutics, Inc. (NASDAQ:PBLA) fell 24.4% to $0.1080 in pre-market trading after gaining around 53% on Tuesday. Panbela Therapeutics, last month, posted a Q3 loss of $0.21 per share.
- OpGen, Inc. (NASDAQ:OPGN) fell 19.2% to $0.1867 in pre-market trading. OpGen shares jumped around 85% on Tuesday after the company announced topline data from its Unyvero urinary tract infections (UTI) clinical trial.
- Rubicon Technology, Inc. (NASDAQ:RBCN) shares fell 17.6% to $1.50 in pre-market trading. Rubicon Technology announced voluntary delisting from the Nasdaq.
- Amesite Inc. (NASDAQ:AMST) fell 14.8% to $0.23 in pre-market trading after dropping 13% on Tuesday.
- iQIYI, Inc. (NASDAQ:IQ) fell 11.6% to $3.40 in pre-market trading after gaining over 9% on Tuesday.
- Engine Gaming and Media, Inc. (NASDAQ:GAME) shares fell 10% to $0.90 in pre-market trading. The company recently announced it has entered into an agreement to combine with GameSquare Esports.
- China Jo-Jo Drugstores, Inc. (NASDAQ:CJJD) fell 9.3% to $5.96 in pre-market trading after dropping more than 7% on Tuesday.
- Reborn Coffee, Inc. (NASDAQ:REBN) fell 9% to $1.22 in pre-market trading.
- LAVA Therapeutics N.V. (NASDAQ:LVTX) fell 8.8% to $4.23 in pre-market trading. LAVA Therapeutics announced updated data from the Phase 1/2a clinical trial of LAVA-051 at the 64th American Society of Hematology Annual Meeting and Exposition.
- Seres Therapeutics, Inc. (NASDAQ:MCRB) fell 8.4% to $6.11 in pre-market trading. The company, last month, posted downbeat quarterly results.
- 111, Inc. (NASDAQ:YI) fell 8.4% to $3.40 in pre-market trading. The company recently posted a narrower loss for its third quarter.
